United States Prostate Cancer Testing Market: Trends, Competition, and Industry Size Forecasts
The United States Prostate Cancer Testing Market is projected to experience significant growth during the forecast period 2018-2028, according to the TechSci Research report titled “United States Prostate Cancer Testing Market - By Region, Competition Forecast and Opportunities, 2018-2028.” This growth can be attributed to the increased prevalence of prostate cancer and the demand for developing cancer testing solutions, as well as key players' acquisitions, expansions, and strategic collaborations in the United States market.
The United States Prostate Cancer Testing Market can be segmented by biomarker type, application, end user, region, and competitive landscape. The market can be categorized by biomarker type into pre-biopsy/post-negative biopsy testing, initial evaluation: prostate-specific antigen (Total PSA, Free PSA), and post-biopsy tissue testing. The pre-biopsy testing segment is expected to experience significant growth in the forecast period due to the rising rate of cancer in men.
In terms of application, the market can be divided into diagnostic biomarkers and prognostic biomarkers. The diagnostic biomarkers segment is anticipated to exhibit an impressive growth rate in the forecast period due to the rising research and development (R&D) activity for the development of prostate cancer testing.
The market can be classified by end user into cancer research institutes, diagnostic laboratories, hospitals and clinics, ambulatory surgical center (ASCs), and others. The hospitals and clinics segment is expected to show an impressive growth rate in the forecast period due to advanced healthcare facilities and growing expenditure in research and development in this segment.
Browse over XX market data Figures spread through?XX Pages and an in-depth TOC on?“United States Prostate Cancer Testing Market”- https://www.techsciresearch.com/report/united-states-prostate-cancer-testing-market/14824.html
Major companies operating in the United States Prostate Cancer Testing Market include:
领英推荐
“United States Prostate Cancer Testing Market is expected to witness significant growth during the forecast period on account of increasing incidence of prostate cancer. An increase in awareness of preventive healthcare on account of growing incidence of chronic diseases further supports the demand for prostate cancer testing market in the United States. Additionally, increase in emergence of players developing new procedures of prostate cancer testing and treatment, is expected to create lucrative opportunities for the market growth in the next few years” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“United States Prostate Cancer Testing Market By Biomarker Type (Pre-Biopsy/Post-Negative Biopsy Testing, Initial Evaluation: Prostate-Specific Antigen (Total PSA, Free PSA), Post-Biopsy Tissue Testing), By Application (Diagnostics Biomarkers, Prognostics Biomarkers), By End User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals and Clinics, Ambulatory Surgical Center (ASCs), and Others), By Region, Competition Forecast & Opportunities, 2018-2028F,”?has evaluated the future growth potential of United States prostate cancer testing market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Prostate Cancer Testing Market.
Download Free Sample Report- https://www.techsciresearch.com/sample-report.aspx?cid=14824
Related Reports: